Skip to main content
Signal8
SANDELL SCOTT D profile photo

Scott D. Sandell

CIK: 0001237289

Transaction Breakdown

Open Market Buys (P)7 (14.9%)

High conviction signal

Open Market Sales (S)5 (10.6%)

Position reduction

Option Exercises (M)4 (8.5%)

Derivative conversions

Awards (A)8 (17.0%)

Compensation grants

Other (G, F, J, C, D, …)23 (48.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (7)

Cloudflare, Inc. logo
NET

Cloudflare, Inc.

Director
Coursera, Inc. logo
COUR

Coursera, Inc.

Director
Korro Bio, Inc. logo
KRRO

Korro Bio, Inc.

10% Owner
Trevi Therapeutics, Inc. logo
TRVI

Trevi Therapeutics, Inc.

10% Owner
SpyGlass Pharma, Inc. logo
SGP

SpyGlass Pharma, Inc.

10% Owner
NeueHealth, Inc. logo
NEUE

NeueHealth, Inc.

10% Owner
MBX Biosciences, Inc. logo
MBX

MBX Biosciences, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (47 total)

  • Cloudflare, Inc. logo
    NET

    Cloudflare, Inc.

    Jun 30, 2026
    Award(A)
    Direct
    842 shares-
  • Coursera, Inc. logo
    COUR

    Coursera, Inc.

    Jun 11, 2026
    Award(A)
    Direct
    34.3K shares-
  • Korro Bio, Inc. logo
    KRRO

    Korro Bio, Inc.

    Mar 10, 2026
    Purchase(P)
    Indirect
    207.1K shares at avg. $11.11$2.3M
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion(C)
    Indirect
    1.4M shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion(C)
    Indirect
    738K shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Purchase(P)
    Indirect
    937.5K shares at avg. $16.00$15.0M
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion(C)
    Indirect
    955K shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion(C)
    Indirect
    402.3K shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion(C)
    Indirect
    1.4M shares-
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Conversion(C)
    Indirect
    1.6M shares-
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    In-the-Money(X)
    Indirect
    189.2K shares at avg. $0.01$2K
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    In-the-Money(X)
    Indirect
    189.2K shares at avg. $0.01$2K
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Sale(S)
    Indirect
    280 shares at avg. $6.75$2K
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Exercise(M)
    Indirect
    186.1K shares at avg. $0.01$2K
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Tax Payment(F)
    Indirect
    276 shares at avg. $6.75$2K
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Disposition(D)
    Indirect
    674.6K shares-
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    In-the-Money(X)
    Indirect
    1.7M shares at avg. $0.01$17K
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Sale(S)
    Indirect
    2.5K shares at avg. $6.75$17K
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    In-the-Money(X)
    Indirect
    607.5K shares at avg. $0.01$6K
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Sale(S)
    Indirect
    900 shares at avg. $6.75$6K
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Exercise(M)
    Indirect
    124.1K shares at avg. $0.01$1K
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Tax Payment(F)
    Indirect
    182 shares at avg. $6.75$1K
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Disposition(D)
    Indirect
    2.4M shares-
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Disposition(D)
    Indirect
    1.2M shares-
  • NeueHealth, Inc. logo
    NEUE

    NeueHealth, Inc.

    Oct 2, 2025
    Sale(S)
    Indirect
    280 shares at avg. $6.75$2K

1-25 of 47

About SANDELL SCOTT D

SANDELL SCOTT D (SEC CIK 0001237289) files insider reports with the SEC as Director of Cloudflare, Inc. (NET), Director of Coursera, Inc. (COUR) and 10% Owner of Korro Bio, Inc. (KRRO). Signal8 also holds filings tied to 4 other companies.

Signal8 holds 12 ownership filings by SANDELL SCOTT D (2 Form 3, 9 Form 4, 1 Form 5), filed between Sep 12, 2024 and Jul 2, 2026. Those filings report 47 transactions, from Sep 16, 2024 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on SANDELL SCOTT D's filings is in TIMONIUM, MD.

Recent filings by SANDELL SCOTT D

  • Jun 30, 2026: Grant or award of NET shares (Form 4, code A).
  • Jun 11, 2026: Grant or award of COUR shares (Form 4, code A).
  • Mar 10, 2026: Open-market purchase of KRRO shares (Form 4, code P).
  • Feb 9, 2026: Conversions of SGP shares (2 lines, Form 4, code C).
  • Feb 9, 2026: Open-market purchase of SGP shares (Form 4, code P).

Other insiders filing for Cloudflare, Inc. (NET)

How to read Form 4 transaction codes